Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)

Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, Rebecca H. Ritchie

Research output: Contribution to journalComment / DebateOtherpeer-review

3 Citations (Scopus)

Abstract

The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.
Original languageEnglish
Pages (from-to)223
Number of pages1
JournalCardiovascular Drugs and Therapy
Volume34
Issue number2
DOIs
Publication statusPublished - 1 Apr 2020

Cite this